1. A new strategy to improve the liver engraftment efficiency of transplanted human biliary tree stem/progenitor cells (hBTSCs): Cell coating with hyaluronic acid. Issue 1 (16th February 2017) Authors: Nevi, L.; Carpino, G.; Costantini, D.; Cardinale, V.; Riccioni, O.; Di Matteo, S.; Melandro, F.; Berloco, P.B.; Reid, L.; Gaudio, E.; Alvaro, D. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Combination of the MEK inhibitor pimasertib with BTK or PI3K-delta inhibitors is active in preclinical models of aggressive lymphomas. (8th March 2016) Authors: Gaudio, E.; Tarantelli, C.; Kwee, I.; Barassi, C.; Bernasconi, E.; Rinaldi, A.; Ponzoni, M.; Cascione, L.; Targa, A.; Stathis, A.; Goodstal, S.; Zucca, E.; Bertoni, F. Journal: Annals of oncology Issue: Volume 27:Number 6(2016:Jun.) Page Start: 1123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. COMBINATORIAL SCREENING OF THE PI3K INHIBITOR COPANLISIB IN T CELL LYMPHOMAS. (June 2017) Authors: Gaudio, E.; Kwee, I.; Spriano, F.; Tarantelli, C.; Rinaldi, A.; Jourdan, T.; Berthold, M.; Arribas, A.; Stathis, A.; Rossi, D.; Liu, N.; Lange, M.; Politz, O.; Zucca, E.; Bertoni, F. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. COPANLISIB SYNERGIES WITH CONVENTIONAL AND TARGETED AGENTS INCLUDING VENETOCLAX IN PRECLINICAL MODELS OF B‐ AND T‐CELL LYMPHOMAS. (12th June 2019) Authors: Tarantelli, C.; Lange, M.; Gaudio, E.; Cascione, L.; Spriano, F.; Kwee, I.; Arribas, A.; Rinaldi, A.; Jourdan, T.; Berthold, M.; Margheriti, F.; Gritti, G.; Rossi, D.; Stathis, A.; Liu, N.; Zucca, E.; Politz, O.; Bertoni, F. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 318 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. DEVELOPMENT OF NOVEL PRECLINICAL MODELS OF SECONDARY RESISTANCE TO THE PI3KΔ INHIBITOR IDELALISIB IN SPLENIC MARGINAL ZONE LYMPHOMA (SMZL). (June 2017) Authors: Arribas, A.J.; Gaudio, E.; Rinaldi, A.; Cascione, L.; Tarantelli, C.; Kwee, I.; Stathis, A.; Zucca, E.; Rossi, D.; Bertoni, F. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis. (February 2019) Authors: Cristoferi, L.; Carpino, G.; Cardinale, V.; Rigamonti, C.; Overi, D.; Zucchini, N.; Leutner, M.; Viganò, M.; Nardi, A.; Gerussi, A.; Ronca, V.; Cadamuro, M.; Bonato, G.; Alvaro, D.; Gaudio, E.; Invernizzi, P.; Mells, G.F.; Carbone, M. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. EG‐011 IS A NOVEL SMALL MOLECULE WITH IN VITRO AND IN VIVO ANTI‐TUMOR ACTIVITY AGAINST LYMPHOMA. (12th June 2019) Authors: Gaudio, E.; Spriano, F.; Tarantelli, C.; Guala, M.; Riveiro, E.; Golino, G.; Lupia, A.; Costa, G.; Rocca, R.; Cascione, L.; Jenni, S.; Tsai, Y.; Bornhauser, B.; Alcaro, S.; Paduano, F.; Trapasso, F.; Zucca, E.; Stathis, A.; Pazzi, N.; Cavalli, F. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Establishment of expanding 3D-organoids cultures from human fetal biliary tree stem cells (hBTSCs) as a potential tool for regenerative medicine and disease modeling. Issue 1 (February 2018) Authors: Safarikia, S.; Cardinale, V.; Carpino, G.; Costantini, D.; Di Matteo, S.; Nevi, L.; Bosco, D.; Gaudio, E.; Alvaro, D. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. ETS1 PHOSPHORYLATION AT THR38 (PETS1) IS ASSOCIATED WITH CELL OF ORIGIN (COO), CELL CYCLE ACTIVATION, AND INFERIOR OUTCOME IN DIFFUSE LARGE B CELL LYMPHOMA (DLBCL). (June 2017) Authors: Chung, E.Y.; Ponzoni, M.; Xu‐Monette, Z.Y.; Cascione, L.; Priebe, V.; Gaudio, E.; Wang, J.; Zhang, J.; Visco, C.; Bhagat, G.; Zucca, E.; Rossi, D.; Young, K.H.; Bertoni, F. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Evaluation of [1, 2]oxazolo[5, 4-e]isoindoles in lymphoma cells. (October 2020) Authors: Barreca, M.; Spanò, V.; Raimondi, M.V.; Montalbano, A.; Bai, R.; Gaudio, E.; Alcaro, S.; Hamel, E.; Bertoni, F.; Barraja, P. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 2 Page Start: S35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗